Radiation for diffuse large B‐cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project

Publisher： John Wiley & Sons Inc

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.7, 2015-04, pp. : 1032-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 776-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of radiation therapy in primary mediastinal large B‐cell lymphoma in rituximab era: A US population‐based analysis

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1052-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-07 ,pp. : 242-246

Karger

Access to resources Recommend Favorite

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole‐body volumetric–metabolic FDG‐PET/CT metrics in diffuse large B‐cell lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 532-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 156-161

Karger

Access to resources Recommend Favorite